provides current information on the clinical and experimental effects of toxic and non-toxic cancer agents and is specifically directed towards breakthroughs in cancer treatment. Among the topics included are cytotoxic chemotherapy, hormonal or biological response modifiers such as interleukins, immunotherapy, drug design, adverse effects of drugs and drug resistance. Within the journal, strong emphasis is placed on papers reporting treatments to alleviate the side-effects of chemotherapy.
An individual subscription includes 10 print issues and full-text online access to all current and back issues.
Visit the journal online at anti-cancerdrugs.com